Strategic Implications of ANVISA’s Regulatory Modernization for Pharmaceutical Market Entry in Brazil
Brazil’s health regulatory agency, ANVISA, is implementing a comprehensive modernization plan aimed at streamlining pharmaceutical evaluations through regulatory reliance, enhanced applicant engagement, structured quality reporting, and selective AI integration, with significant implications for international pharmaceutical companies seeking market access.